Cargando…
Therapeutic mechanisms of the medicine and food homology formula Xiao-Ke-Yin on glucolipid metabolic dysfunction revealed by transcriptomics, metabolomics and microbiomics in mice
BACKGROUND: In recent decades, the prevalence of metabolic diseases, particularly diabetes, hyperlipidemia, obesity, and non-alcoholic fatty liver disease (NAFLD), has increased dramatically, causing great public health and economic burdens worldwide. Traditional Chinese medicine (TCM) serves as an...
Autores principales: | Li, Mei, Cheng, Ding, Peng, Chuan, Huang, Yujiao, Geng, Jie, Huang, Guangrui, Wang, Ting, Xu, Anlong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193706/ https://www.ncbi.nlm.nih.gov/pubmed/37202792 http://dx.doi.org/10.1186/s13020-023-00752-6 |
Ejemplares similares
-
Network Pharmacology Analysis of Traditional Chinese Medicine Formula Xiao Ke Yin Shui Treating Type 2 Diabetes Mellitus
por: Zhou, Jiewen, et al.
Publicado: (2019) -
Jiang Tang Xiao Ke Granule, a Classic Chinese Herbal Formula, Improves the Effect of Metformin on Lipid and Glucose Metabolism in Diabetic Mice
por: Zhang, Yi, et al.
Publicado: (2016) -
Effects of Xiao Chengqi Formula on Slow Transit Constipation by Assessing Gut Microbiota and Metabolomics Analysis in vitro and in vivo
por: Zhou, Qian, et al.
Publicado: (2022) -
Corrigendum: Effects of Xiao Chengqi formula on slow transit constipation by assessing gut microbiota and metabolomics analysis in vitro and in vivo
por: Zhou, Qian, et al.
Publicado: (2023) -
BuFeiXiaoJiYin ameliorates the NLRP3 inflammation response and gut microbiota in mice with lung cancer companied with Qi-yin deficiency
por: Jiang, Rui-yuan, et al.
Publicado: (2022)